CR7380A - ORAL FORMULATION OF FLUDARA PURISIMO WITH QUICK RELEASE OF ACTIVE INGREDIENT - Google Patents

ORAL FORMULATION OF FLUDARA PURISIMO WITH QUICK RELEASE OF ACTIVE INGREDIENT

Info

Publication number
CR7380A
CR7380A CR7380A CR7380A CR7380A CR 7380 A CR7380 A CR 7380A CR 7380 A CR7380 A CR 7380A CR 7380 A CR7380 A CR 7380A CR 7380 A CR7380 A CR 7380A
Authority
CR
Costa Rica
Prior art keywords
fludara
purisimo
active ingredient
quick release
oral formulation
Prior art date
Application number
CR7380A
Other languages
Spanish (es)
Inventor
Ulf Tilstam
Ralph Lipp
Johannes-Wilhelm Tack
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of CR7380A publication Critical patent/CR7380A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se refiere a una formulacion para comprimidos de liberacion rapida con > 99,19 de fludara puro (Fludara purisimo) como ingrediente activo en una composicion definida en las impurezas residuales.It refers to a formulation for rapid-release tablets with> 99.19 pure fludara (Fludara purisimo) as an active ingredient in a composition defined in residual impurities.

CR7380A 2001-12-20 2004-06-24 ORAL FORMULATION OF FLUDARA PURISIMO WITH QUICK RELEASE OF ACTIVE INGREDIENT CR7380A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10165510 2001-12-20

Publications (1)

Publication Number Publication Date
CR7380A true CR7380A (en) 2006-02-07

Family

ID=44839204

Family Applications (1)

Application Number Title Priority Date Filing Date
CR7380A CR7380A (en) 2001-12-20 2004-06-24 ORAL FORMULATION OF FLUDARA PURISIMO WITH QUICK RELEASE OF ACTIVE INGREDIENT

Country Status (1)

Country Link
CR (1) CR7380A (en)
  • 2004

Similar Documents

Publication Publication Date Title
ECSP055528A (en) PHARMACEUTICAL COMPOSITION THAT HAS A UNIFORM DISTRIBUTION AND POWER OF FARMACO
AR106561A2 (en) PHARMACEUTICAL COMPOSITION CONTAINING A TETRAHYDROPHOLIC ACID
ES2191977T3 (en) SOLUTIONS AND DISPERSIONS IN SOLID STATE OF PHARMACOS LITTLE SOLUBLES IN WATER.
GT200600200A (en) PHARMACEUTICAL COMPOSITION CONTAINING GESTAGENS AND / OR STROGENS AND 5-METHYL- (6S) -TETRAHYDROPHOLATE
AR054114A1 (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE IMATINIB AND A DELAYER OF LIBERATION
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
TW200501965A (en) Highly pure fondaparinux sodium composition,process for preparing said composition and pharmaceutical compositions containing it as active principle
GT200200078A (en) METHOD FOR MANUFACTURING A LOW DOSE PHARMACEUTICAL COMPOSITION THAT HAS A DISTRIBUTION AND POWER OF THE UNIFORM PHARMACO.
ECSP066860A (en) ORAL MATRIX FORMULATIONS THAT INCLUDE LICARBAZEPINA
ATE347358T1 (en) FLOATING ORAL FORMULATIONS WITH CONTROLLED RELEASE OF BETAIN
ECSP045185A (en) ORAL FORMULATION OF PURE FLUDARA WITH QUICK RELEASE OF ACTIVE INGREDIENT
CR9839A (en) PHOTOSTABLE PHARMACEUTICAL COMPOSITION CONTAINING BRIVUDINE FOR THE TREATMENT OF HERPETIC CHERATITIS
CL2004001843A1 (en) COMBINATION OF (A) AT LEAST A 2,5-DIHYDROBENCENOSULPHONIC DERIVATIVE, AS CALCIUM DOBEYLATE, ETHAMSYLATE AND PERSILATE, AND (B) AT LEAST A MODULATOR OF POTASSIUM CHANNELS, PHARMACEUTICAL COMPOSITION CONTAINING AND USE AS A MEDICATION IN PROFILA
ES2189739T3 (en) COMPOSITIONS OF BETAHISTINE CONTROLLED LIBERATION.
CR7380A (en) ORAL FORMULATION OF FLUDARA PURISIMO WITH QUICK RELEASE OF ACTIVE INGREDIENT
PE20060015A1 (en) PROLONGED RELEASE COMPOSITIONS INCLUDING TORASEMIDE AND A MATRIX FORMING POLYMER
ECSP003685A (en) ORAL FORMULATIONS OF CONTROLLED RELEASE
DK1292303T3 (en) Stable pharmaceutical formulation comprising torsemide modification II
RU2009139485A (en) PHARMACEUTICAL COMPOSITION CONSISTING OF CANDEXARTAN CILEXETIL AND METHOD FOR PRODUCING IT
CU23299A3 (en) ORAL FORMULATION OF FLUDARA PURÃ SIMO WITH QUICK RELEASE OF ACTIVE INGREDIENT
PL378106A1 (en) Method for producing a pharmaceutical composition in the form of fibrate-containing tablets and tablets produced by said method
AR040764A1 (en) PHARMACEUTICAL FORMULATIONS OF EPINASTINE, PSEUDOEFEDRINE AND METHYLFEDRINE
AR020998A1 (en) METAMIZOL CONTROLLED RELEASE FORMULATIONS
AU2003202550A1 (en) Pharmaceutical formulations with modified release
AR026451A1 (en) SILILATED HETEROCICLIC COMPOUNDS

Legal Events

Date Code Title Description
FC90 Suspension of granting procedure